{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-132744","form_type":"8-K","ticker":"MSPR","cik":"0001802450","company_name":"MSP Recovery, Inc.","filed_at":"2024-12-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.689646+00:00","generated_at":"2026-05-29T09:58:29.984552+00:00","sec_items":["3.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"MSP Recovery regains Nasdaq compliance, reports $2M pharma settlement and Nomura waiver","bullets":["Nasdaq confirmed bid price deficiency cured; Class A common stock continues listing on Nasdaq Global Market.","Reached preliminary $2M settlement in pharmaceutical RICO case; settlement provides data to pursue other manufacturers.","Ongoing settlement negotiations with P&C insurers and pharma/medical device manufacturers; five P&C settlements in 2024 totaling >$10M.","Nomura waived up to $4M of promissory note obligations until March 2025 for operations, increasing liquidity.","Acquired additional MSP claims with >$10.6B paid amount for $2M to enhance recovery efforts."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-132744","json":"https://secwatch.observer/filing/0000950170-24-132744.json","markdown":"https://secwatch.observer/filing/0000950170-24-132744.md","text":"https://secwatch.observer/filing/0000950170-24-132744.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1802450/000095017024132744/0000950170-24-132744-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1802450/000095017024132744/lifw-20241203.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T09:58:29.984552+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"11169a194f784e86ced101071117a041f617c931","claim":"MSP Recovery, Inc. received a nasdaq compliance regained notice regarding minimum bid price (rules 5450(a)(1)).","evidence_excerpt":"December 3, 2024, MSP Recovery, Inc. (“the Company”) received correspondence from Nasdaq stating that the Company’s previously disclosed bid price deficiency has been cured, and that the Company has regained compliance with Listing Rule 5450(a)(1). The Company’s Class A common stock will continue to be listed and traded on Nasdaq, subject to continued compliance with applicable Nasdaq listing standards.","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1802450/000095017024132744/0000950170-24-132744-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"compliance regained"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5450(a)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}